Ng George K 4
4 · Processa Pharmaceuticals, Inc. · Filed Jan 29, 2025
Insider Transaction Report
Form 4
Ng George K
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2025-01-27$0.80/sh+87,200$69,542→ 87,200 total(indirect: George Ng IRRA FBO: George Ng)
Holdings
- 20,000(indirect: By Trust)
Common Stock